|Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer|
P Jabbarzadeh Kaboli, A Rahmat, P Ismail, KH Ling
European Journal of Pharmacology 740, 584-595, 2014
|MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment|
PJ Kaboli, A Rahmat, P Ismail, KH Ling
Pharmacological research 97, 104-121, 2015
|Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer–A comprehensive review from chemotherapy to immunotherapy|
PJ Kaboli, F Salimian, S Aghapour, S Xiang, Q Zhao, M Li, X Wu, F Du, ...
Pharmacological research 156, 104806, 2020
|m1A regulated genes modulate PI3K/AKT/mTOR and ErbB pathways in gastrointestinal cancer|
Y Zhao, Q Zhao, PJ Kaboli, J Shen, M Li, X Wu, J Yin, H Zhang, Y Wu, ...
Translational oncology 12 (10), 1323-1333, 2019
|An ethnobotanical survey of medicinal plants used by indigenous people in Zangelanlo district, Northeast Iran|
MS Amiri, P Jabbarzadeh, M Akhondi
J Med Plants Res 6 (5), 749-753, 2012
|Engineered TCR-T cell immunotherapy in anticancer precision medicine: pros and cons|
Q Zhao, Y Jiang, S Xiang, PJ Kaboli, J Shen, Y Zhao, X Wu, F Du, M Li, ...
Frontiers in immunology 12, 658753, 2021
|Antitumor effects of berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study|
P Jabbarzadeh Kaboli, MPY Leong, P Ismail, KH Ling
Pharmacological Reports 71, 13-23, 2019
|Conditional reprogramming: next generation cell culture|
X Wu, S Wang, M Li, J Li, J Shen, Y Zhao, J Pang, Q Wen, M Chen, B Wei, ...
Acta Pharmaceutica Sinica B 10 (8), 1360-1381, 2020
|CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild‑type non‑small‑cell lung cancer cells|
J Yin, H Zhang, X Wu, Y Zhang, J Li, J Shen, Y Zhao, Z Xiao, L Lu, ...
International journal of molecular medicine 45 (6), 1783-1792, 2020
|Targets and mechanisms of sulforaphane derivatives obtained from cruciferous plants with special focus on breast cancer–contradictory effects and future perspectives|
PJ Kaboli, MA Khoshkbejari, M Mohammadi, A Abiri, R Mokhtarian, ...
Biomedicine & Pharmacotherapy 121, 109635, 2020
|A review of Penthorum chinense Pursh for hepatoprotection: traditional use, phytochemistry, pharmacology, toxicology and clinical trials|
A Wang, M Li, H Huang, Z Xiao, J Shen, Y Zhao, J Yin, PJ Kaboli, J Cao, ...
Journal of ethnopharmacology 251, 112569, 2020
|Metagenome analysis of intestinal bacteria in healthy people, patients with inflammatory bowel disease and colorectal cancer|
Y Ma, Y Zhang, H Jiang, S Xiang, Y Zhao, M Xiao, F Du, H Ji, PJ Kaboli, ...
Frontiers in cellular and infection microbiology 11, 599734, 2021
|Characterization of chemical composition and prebiotic effect of a dietary medicinal plant Penthorum chinense Pursh|
J Yin, W Ren, B Wei, H Huang, M Li, X Wu, A Wang, Z Xiao, J Shen, ...
Food chemistry 319, 126568, 2020
|Identification of prognostic genes in the tumor microenvironment of hepatocellular carcinoma|
S Xiang, J Li, J Shen, Y Zhao, X Wu, M Li, X Yang, PJ Kaboli, F Du, ...
Frontiers in Immunology 12, 653836, 2021
|Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy|
Y Wu, J Li, PJ Kaboli, J Shen, X Wu, Y Zhao, H Ji, F Du, Y Zhou, Y Wang, ...
Pharmacological research 155, 104691, 2020
|Comprehensive understanding of B7 family in gastric cancer: expression profile, association with clinicopathological parameters and downstream targets|
D Li, S Xiang, J Shen, M Xiao, Y Zhao, X Wu, F Du, H Ji, M Li, Q Zhao, ...
International journal of biological sciences 16 (4), 568, 2020
|Molecular modeling, dynamics simulations, and binding efficiency of berberine derivatives: a new group of RAF inhibitors for cancer treatment|
P Jabbarzadeh Kaboli, P Ismail, KH Ling
PLoS One 13 (3), e0193941, 2018
|m5C RNA Methylation Primarily Affects the ErbB and PI3K–Akt Signaling Pathways in Gastrointestinal Cancer|
S Xiang, Y Ma, J Shen, Y Zhao, X Wu, M Li, X Yang, PJ Kaboli, F Du, H Ji, ...
Frontiers in molecular biosciences 7, 599340, 2020
|Long non-coding RNAs: potential biomarkers and targets for hepatocellular carcinoma therapy and diagnosis|
D Yuan, Y Chen, X Li, J Li, Y Zhao, J Shen, F Du, PJ Kaboli, M Li, X Wu, ...
International Journal of Biological Sciences 17 (1), 220, 2021
|Analysis of key genes regulating the warburg effect in patients with gastrointestinal cancers and selective inhibition of this metabolic pathway in liver cancer cells|
X Zhang, J Guo, PJ Kaboli, Q Zhao, S Xiang, J Shen, Y Zhao, F Du, X Wu, ...
OncoTargets and therapy 13, 7295, 2020